Farshad Mirzavi

TL;DR: An overview of liposome-based targeted drug delivery methods for melanoma is presented in this article, where the new insights regarding the efficacy and clinical significance of combinatorial treatment with liposomal formulations with immunotherapy and conventional therapies in melanoma patients are discussed.

TL;DR: In this article , the authors found that SP acting via neurokinin-1-receptor (NK1R) promotes tumorigenicity in many human malignant tumors, but its pro-tumorigenic functions and the therapeutic effects of its inhibition in prostate cancer remain unclear.

TL;DR: This paper aims to comprehensively review the therapeutic potential of CD73 ectonucleotidase targeting in melanoma, and depicts the metabolism and signaling ofCD73-derived adenosine along with its progressive role in development of melanoma.

TL;DR: Wang et al. as discussed by the authors used a liposomal formulation as a siRNA carrier to silence PD-1 expression in T cells and investigate it's in vivo antitumor efficacy.

TL;DR: Zerumbone significantly inhibited the migration of HT-29 cells and decreased MMP-2/-9 mRNA expression and activity and could be developed as a promising natural agent for future CRC therapy.